who should not take glp-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 medications like Ozempic are

BPC-157 also pairs well with MK-677 (oral growth hormone secretagogue) for enhanced repair environments, though MK-677 requires its own protocol considerations

But unlike approved peptides used in medicine, such as insulin and GLP-1 drugs like Ozempic, Health Canada tells CBC "unauthorized peptide products sold for wellness purposes have not been assessed for safety, quality or effectiveness." And yet, CBC News found doctors promoting and prescribing a popular unauthorized peptide called Body Protection Compound-157 (BPC-157) that is touted to help accelerate muscle growth and tissue repair

Retrieved Dec 20, 2023, from Wu SH, Chen KL, Hsu C, Chen HC, Chen JY, Yu SY, Shiu YJ

M., Merinero, B., Wajner, M., Troncoso, M., Williams, M., Walter, J